Credit: Shutterstock photoBecton, Dickinson and CompanyBDX , more commonly known as BD, recently announced the FDA approval for its BD Totalys MultiProcessor and BD Totalys SlidePrep instruments.
The products, along with the BD FocalPoint SlideProfiler, cover the entire BD Totalys System which offers a highly customizable, automated liquid-based cytology solution to clinical laboratories.
We believe that the new offerings will help BD gain domestic market traction, which in turn, will drive top-line growth. Additionally, we are upbeat about BD's expanding product pipeline.
Last month, BD's new safety blood collection system -- BD Vacutainer UltraTouch Push Button Blood Collection Set - received FDA approval as well as European CE marking. The recognition will allow BD to market the collection set in both the U.S and Europe.
The collection set has been found more patient friendly as compared to other systems. BD Vacutainer UltraTouch uses the company's proprietary PentaPoint Comfort 5-bevel needle technology, which combined with the BD RightGauge technology, reduces penetration force by up to 32% during blood collection.
In February this year, the FDA approved the BD FACSPresto system and BD FACSPresto CD4/Hb Cartridge that can be used to detect CD4 T lymphocytes and hemoglobin (Hb) concentration in whole blood samples of HIV/AIDS patients.
The user-friendly device weighs only 6 kilograms and has a touchscreen and language-independent user interface. The device uses a proprietary dried reagents cartridge to offer increased stability across a wide range of storage conditions. It can process a maximum of 80 tests in a day.
Moreover, products like BD MAX Enteric Parasite Panel (Sep 2015) and Vertebral Balloon Systems (Dec 2015) expand BD's offerings into new fields like infectious gastroenteritis diagnosis and spine augmentation device markets.
Zacks Rank and Key Picks
Currently, BD has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical instruments space are Abiomed ABMD , CryoLife CRY and Luminex LMNX . All the stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
LUMINEX CORP (LMNX): Free Stock Analysis Report
ABIOMED INC (ABMD): Free Stock Analysis Report
CRYOLIFE INC (CRY): Free Stock Analysis Report
BECTON DICKINSO (BDX): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
